refund path triage, liquidation timing, source evidence, and broker review can materially change landed cost. Use this page to keep HTS classification, origin evidence, tariff layers, source URLs, retrieval dates, freight, fees, and open broker questions in one planning workflow.
Tariff refunds: separate possible refund paths from wishful accounting
Understand tariff refund paths such as drawback, exclusions, protests, court implementation, and the evidence importers need to preserve.
Treat the page as a checklist, not a filing determination.
Origin, valuation, and product facts can change the result.
Preserve assumptions and sources before asking for review.
Start with the product facts
For Shipment being reviewed for possible tariff refund, collect the product description, materials, use, photos, supplier quote, origin evidence, valuation basis, freight, insurance, and the best HTS candidate before modeling cost.
Keep each tariff layer separate
Do not collapse refund path triage, liquidation timing, source evidence, and broker review into a single blended rate. Keep base duty, additional tariffs, AD/CVD, quotas, safeguards, preference programs, and uncertainty notes as separate fields.
Broker review questions
Ask whether the HTS candidate is correct, whether any Chapter 99 instruction applies, whether exclusions or trade remedies change the result, and what documents should be kept before entry.
规划用途提示:TariffsChart 不是报关行、律师事务所、税务顾问或政府机构。归类、税率、生效日期、排除项和申报指引都应通过官方来源和合格专业人士复核。
常见问题
Can I use this page as the final tariff answer?
No. It is a planning checklist. Final treatment depends on official sources, product facts, entry timing, and qualified broker or professional review.
What should I put into the calculator first?
Start with the product description, origin, HTS candidate, customs value, freight, insurance, base duty, and any additional tariff assumption that has a source.
When should I contact a broker?
Before placing a purchase order or quoting a customer, especially if classification, origin, Chapter 99, AD/CVD, Section 232, or preference eligibility is unresolved.